CHEST Australia

CHEST Australia: a Phase II randomised controlled trial of a complex intervention to promote consulting with symptoms of cancer

Lung cancer is the leading cause of cancer deaths in Australia. Testing novel approaches to earlier diagnosis of lung cancer to improve outcomes has been identified as a research priority by Cancer Australia. This multi-site, phase II randomised controlled trial builds on a Scottish trial of a theoretically-based intervention aimed at promoting earlier help-seeking in people at higher risk of lung cancer and increasing health literacy among adults at high risk of lung cancer.

Current status:



Emery J, Murray S, Walter F et al. The Chest Australia Trial: a randomised controlled trial of an intervention to increase consultation rates in smokers at risk of lung cancer. Thorax. January 2019 Murray SR, Kutzer Y, Habgood E, Murchie P, Walter FM, Mazza D, Shahid S, Emery JD; Reducing barriers to consulting a General Practitioner in patients at increased risk of lung cancer: a qualitative evaluation of the CHEST Australia intervention. Family Practice, Volume 34, Issue 6, 16 November 2017, Pages 740–746.

Scroll to Top